201 related articles for article (PubMed ID: 35832191)
21. The sub-molecular characterization identification for cervical cancer.
Mo X; Wang N; He Z; Kang W; Wang L; Han X; Yang L
Heliyon; 2023 Jun; 9(6):e16873. PubMed ID: 37484385
[TBL] [Abstract][Full Text] [Related]
22. Gene signatures, immune infiltration, and drug sensitivity based on a comprehensive analysis of m6a RNA methylation regulators in cervical cancer.
Lu X; Li R; Ying Y; Zhang W; Wang W
J Transl Med; 2022 Sep; 20(1):385. PubMed ID: 36058934
[TBL] [Abstract][Full Text] [Related]
23. TPM3: a novel prognostic biomarker of cervical cancer that correlates with immune infiltration and promotes malignant behavior
Zhao YC; Wang TJ; Qu GH; She LZ; Cui J; Zhang RF; Qu HD
Am J Cancer Res; 2023; 13(7):3123-3139. PubMed ID: 37559998
[TBL] [Abstract][Full Text] [Related]
24. ZIC5 promotes aggressiveness and cancer stemness in cervical squamous cell carcinoma.
Jia Q; Song J; Xu T; Liu J; Chai J; Yang Y; Li L; Li M; Yang X
Pathol Res Pract; 2023 Jan; 241():154268. PubMed ID: 36495760
[TBL] [Abstract][Full Text] [Related]
25. Tumor purity as a prognosis and immunotherapy relevant feature in cervical cancer.
Deng Y; Song Z; Huang L; Guo Z; Tong B; Sun M; Zhao J; Zhang H; Zhang Z; Li G
Aging (Albany NY); 2021 Nov; 13(22):24768-24785. PubMed ID: 34844217
[TBL] [Abstract][Full Text] [Related]
26. Pain-Related Gene Solute Carrier Family 24 Member 3 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma: A Study via Integrated Bioinformatics Analyses and Experimental Verification.
Zhou S; Jin Q; Yao H; Ying J; Tian L; Jiang X; Yang Y; Jiang X; Gao W; Zhang W; Zhu Y; Cao W
Comput Math Methods Med; 2023; 2023():4164232. PubMed ID: 36798148
[TBL] [Abstract][Full Text] [Related]
27. The immune landscape and prognostic analysis of CXCL8 immune-related genes in cervical squamous cell carcinoma.
Zhang X; Yang J; Feng Q; Gu L; Qin G; Cheng C; Hou S; Shi Z
Environ Toxicol; 2024 Apr; ():. PubMed ID: 38597597
[TBL] [Abstract][Full Text] [Related]
28. Unveiling the role of HACE1 in cervical cancer: implications for human papillomavirus infection and prognosis.
Xiang S; Wang M; Li Q; Yang Z
Transl Cancer Res; 2024 May; 13(5):2175-2186. PubMed ID: 38881936
[TBL] [Abstract][Full Text] [Related]
29. Exploring Potential Regulatory Anesthetic Drugs Based on RNA Binding Protein and Constructing CESC Prognosis Model: A Study Based on TCGA Database.
Zheng Y; Meng XW; Yang JP
Front Surg; 2022; 9():823566. PubMed ID: 35449547
[TBL] [Abstract][Full Text] [Related]
30. Identification of candidate miRNA biomarkers correlated with the prognosis of cell carcinoma and endocervical adenocarcinoma via integrated bioinformatics analysis.
Zhi S; Jiang B; Yu W; Li Y; Wang H; Zhou T; Li N
Am J Transl Res; 2022; 14(11):8146-8155. PubMed ID: 36505295
[TBL] [Abstract][Full Text] [Related]
31. The Clinical Significance and Immunization of MSMO1 in Cervical Squamous Cell Carcinoma Based on Bioinformatics Analysis.
Zheng G; Wang Z; Fan Y; Wang T; Zhang L; Wang M; Chen S; Jiang L
Front Genet; 2021; 12():705851. PubMed ID: 34759952
[No Abstract] [Full Text] [Related]
32. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
[TBL] [Abstract][Full Text] [Related]
33. MLK4 as an immune marker and its correlation with immune infiltration in Cervical squamous cell carcinoma and endocervical adenocarcinoma(CESC).
Gong M; Shen F; Li Y; Ming L; Hong L
PLoS One; 2023; 18(8):e0290462. PubMed ID: 37594950
[TBL] [Abstract][Full Text] [Related]
34. LINC00963 May Be Associated with a Poor Prognosis in Patients with Cervical Cancer.
Chang A; Wang P; Ren J
Med Sci Monit; 2022 Jul; 28():e935070. PubMed ID: 35818328
[TBL] [Abstract][Full Text] [Related]
35. Integration of scRNA-Seq and TCGA RNA-Seq to Analyze the Heterogeneity of HPV+ and HPV- Cervical Cancer Immune Cells and Establish Molecular Risk Models.
Wei E; Reisinger A; Li J; French LE; Clanner-Engelshofen B; Reinholz M
Front Oncol; 2022; 12():860900. PubMed ID: 35719936
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Significance of Alternative Splicing Genes in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
Wang X; Tang W; Lu Y; You J; Han Y; Zheng Y
Int J Gen Med; 2021; 14():7933-7949. PubMed ID: 34785939
[TBL] [Abstract][Full Text] [Related]
37. Increased ATG5 Expression Predicts Poor Prognosis and Promotes EMT in Cervical Carcinoma.
Zhou S; Wang X; Ding J; Yang H; Xie Y
Front Cell Dev Biol; 2021; 9():757184. PubMed ID: 34901004
[TBL] [Abstract][Full Text] [Related]
38. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Signatures Based on Ferroptosis- and Immune-Related Genes for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
Xing C; Yin H; Yao ZY; Xing XL
Front Oncol; 2021; 11():774558. PubMed ID: 35087751
[TBL] [Abstract][Full Text] [Related]
40. Acetyl Coenzyme A Synthase 2 Acts as a Prognostic Biomarker Associated with Immune Infiltration in Cervical Squamous Cell Carcinoma.
Li CJ; Chiu YH; Chang C; Chang YI; Sheu JJ; Chiang AJ
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34206705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
